Hepatocellular carcinoma - PubMed (original) (raw)
Review
Hepatocellular carcinoma
D F Schafer et al. Lancet. 1999.
Abstract
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.
Comment in
- Hepatocellular carcinoma.
Bell BM. Bell BM. Lancet. 1999 Jul 17;354(9174):253. doi: 10.1016/S0140-6736(05)66320-9. Lancet. 1999. PMID: 10421328 No abstract available. - Hepatocellular carcinoma.
Kashyap AS, Kashyap S. Kashyap AS, et al. Lancet. 1999 Jul 17;354(9174):253. doi: 10.1016/s0140-6736(05)66322-2. Lancet. 1999. PMID: 10421329 No abstract available. - Hepatocellular carcinoma.
Deans C, Leslie P. Deans C, et al. Lancet. 1999 Jul 17;354(9174):253-4. doi: 10.1016/S0140-6736(05)66323-4. Lancet. 1999. PMID: 10421330 No abstract available.
Similar articles
- [Hepatocellular carcinoma--epidemiology and treatment].
Małkowski P, Pacholczyk M, Łagiewska B, Adadyński L, Wasiak D, Kwiatkowski A, Chmura A, Czerwiński J. Małkowski P, et al. Przegl Epidemiol. 2006;60(4):731-40. Przegl Epidemiol. 2006. PMID: 17682755 Review. Polish. - Hepatocellular carcinoma.
Desjardins LA. Desjardins LA. Clin J Oncol Nurs. 2002 Mar-Apr;6(2):107-8. doi: 10.1188/02.CJON.107-108. Clin J Oncol Nurs. 2002. PMID: 11889672 Review. - Hepatocellular carcinoma.
Naugler WE, Schwartz JM. Naugler WE, et al. Dis Mon. 2008 Jul;54(7):432-44. doi: 10.1016/j.disamonth.2008.03.005. Dis Mon. 2008. PMID: 18570913 No abstract available. - Hepatocellular carcinoma: status in the era of liver transplantation.
Singhal A, Jabbour N. Singhal A, et al. J Okla State Med Assoc. 2009 Dec;102(12):355-61. J Okla State Med Assoc. 2009. PMID: 20131731 Review. No abstract available. - Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia.
Umoh NJ, Lesi OA, Mendy M, Bah E, Akano A, Whittle H, Hainaut P, Kirk GD. Umoh NJ, et al. Liver Int. 2011 Feb;31(2):215-21. doi: 10.1111/j.1478-3231.2010.02418.x. Epub 2010 Dec 8. Liver Int. 2011. PMID: 21143369
Cited by
- Serum/plasma microRNAs as biomarkers for HBV-related hepatocellular carcinoma in China.
Yin W, Zhao Y, Ji YJ, Tong LP, Liu Y, He SX, Wang AQ. Yin W, et al. Biomed Res Int. 2015;2015:965185. doi: 10.1155/2015/965185. Epub 2015 Jan 22. Biomed Res Int. 2015. PMID: 25688372 Free PMC article. Review. - Hepatocellular carcinoma and nonalcoholic steatohepatitis developing during long-term administration of valproic acid.
Sato K, Ueda Y, Ueno K, Okamoto K, Iizuka H, Katsuda S. Sato K, et al. Virchows Arch. 2005 Dec;447(6):996-9. doi: 10.1007/s00428-005-0042-z. Epub 2005 Aug 17. Virchows Arch. 2005. PMID: 16133366 - Gene expression profiles of hepatoma cell line HLE.
Liu LX, Liu ZH, Jiang HC, Zhang WH, Qi SY, Hu J, Wang XQ, Wu M. Liu LX, et al. World J Gastroenterol. 2003 Apr;9(4):683-7. doi: 10.3748/wjg.v9.i4.683. World J Gastroenterol. 2003. PMID: 12679910 Free PMC article. - Comparison of gene expression in liver regeneration and hepatocellular carcinoma formation.
Yin L, Wang Y, Guo X, Xu C, Yu G. Yin L, et al. Cancer Manag Res. 2018 Nov 15;10:5691-5708. doi: 10.2147/CMAR.S172945. eCollection 2018. Cancer Manag Res. 2018. PMID: 30532592 Free PMC article. - Localized Hepatocellular Carcinoma.
Jeyarajah DR. Jeyarajah DR. Curr Treat Options Gastroenterol. 2000 Dec;3(6):463-472. doi: 10.1007/s11938-000-0035-6. Curr Treat Options Gastroenterol. 2000. PMID: 11096607
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical